In a report released today, Emmanuel Papadakis from Deutsche Bank maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), with a ...

Though GSK is definitely not the best large-cap drugmaker to have in one's portfolio, we believe there is potential for its ...

GSK's consumer health spinout Haleon started trading on the London Stock Exchange this morning, making its debut with a price of 330 pence and a market valuation of around £31 billion ($37 billion).

News for GlaxoSmithKline Consumer Healthcare Ltd. Google.org Grants $1 Million to Karya for AI Upskilling in India Google.org awards USD 1 million to Karya, an Indian non-profit, to empower low-income ...

Puneet Gulati has been appointed as the Chief Marketing Officer (CMO) at Sleepwell, a role he began in September 2024, as ...

Barclays analyst Emily Field maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £14.50. The ...

GSK (GSK) announced the Committee for Medicinal Products for Human Use, CHMP, of the European Medicines Agency, EMA, has recommended expanding the approval of Jemperli in combination with chemotherapy ...

Vishal Mega Mart’s IPO will open on December 11, aiming to raise Rs 8,000 crore via an offer for sale (OFS). The shares are currently trading at a 31% premium in the grey market, with today’s GMP at ...

GlaxoSmithKline (GSK ... first announced the “strategic review” of Horlicks and other consumer healthcare nutrition products in March this year. Proceeds from a potential sale could be ...

Teva Pharmaceutical Industries Ltd. ADR 1.42% $19.56B ...

GlaxoSmithKline PLC creates, discovers, develops, manufactures and markets pharmaceutical products including respiratory and antiviral, vaccines, over-the-counter (OTC) medicines and health-related ...